CD5 and B-cell chronic lymphocytic leukemia: The relationship between VDAC1 levels and the relative amounts of CD19, a B lymphocyte marker, and CD5, a T-lymphocyte marker (CD19+/CD5+) cells (representing CLL cancerous cells) in PBMCs isolated from each patient was assessed using specific antibodies (Fig 5).